Literature DB >> 34081779

Learning the full impact of migraine through patient voices: A qualitative study.

Paige M Estave1, Summerlyn Beeghly2, Reid Anderson2, Caitlyn Margol2, Mariam Shakir2, Geena George2, Anissa Berger2, Nathaniel O'Connell3, Rebecca Burch4, Niina Haas5, Scott W Powers6, Elizabeth Seng7,8, Dawn C Buse8, Richard B Lipton8, Rebecca Erwin Wells2.   

Abstract

OBJECTIVE: To better characterize the ways that migraine affects multiple domains of life.
BACKGROUND: Further understanding of migraine burden is needed.
METHODS: Adults with migraine randomized to mindfulness-based stress reduction or headache education arms (n = 81) in two separate randomized clinical trials participated in semistructured in-person qualitative interviews conducted after the interventions. Interviews queried participants on migraine impact on life and were audio-recorded, transcribed, and summarized into a framework matrix. A master codebook was created until meaning saturation was reached and magnitude coding established code frequency. Themes and subthemes were identified using a constructivist grounded theory approach.
RESULTS: Despite most participants being treated with acute and/or prophylactic medications, 90% (73/81) reported migraine had a negative impact on overall life, with 68% (55/81) endorsing specific domains of life impacted and 52% (42/81) describing impact on emotional health. Six main themes of migraine impact emerged: (1) global negative impact on overall life; (2) impact on emotional health; (3) impact on cognitive function; (4) impact on specific domains of life (work/career, family, social); (5) fear and avoidance (pain catastrophizing and anticipatory anxiety); and (6) internalized and externalized stigma. Participants reported how migraine (a) controls life, (b) makes life difficult, and (c) causes disability during attacks, with participants (d) experiencing a lack of control and/or (e) attempting to push through despite migraine. Emotional health was affected through (a) isolation, (b) anxiety, (c) frustration/anger, (d) guilt, (e) mood changes/irritability, and (f) depression/hopelessness. Cognitive function was affected through concentration and communication difficulties.
CONCLUSIONS: Migraine has a global negative impact on overall life, cognitive and emotional health, work, family, and social life. Migraine contributes to isolation, frustration, guilt, fear, avoidance behavior, and stigma. A greater understanding of the deep burden of this chronic neurological disease is needed to effectively target and treat what is most important to those living with migraine.
© 2021 American Headache Society.

Entities:  

Keywords:  chronic illness; coping; disease burden; headache; patient-centered; quality of life

Mesh:

Year:  2021        PMID: 34081779      PMCID: PMC8428538          DOI: 10.1111/head.14151

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.311


  50 in total

Review 1.  Chronic pain: a review of its epidemiology and associated factors in population-based studies.

Authors:  Sarah E E Mills; Karen P Nicolson; Blair H Smith
Journal:  Br J Anaesth       Date:  2019-05-10       Impact factor: 9.166

2.  Constructing Grounded Theory: A practical guide through qualitative analysis Kathy Charmaz Constructing Grounded Theory: A practical guide through qualitative analysis Sage 224 £19.99 0761973532 0761973532 [Formula: see text].

Authors: 
Journal:  Nurse Res       Date:  2006-07-01

Review 3.  Migraine: Epidemiology, Burden, and Comorbidity.

Authors:  Rebecca C Burch; Dawn C Buse; Richard B Lipton
Journal:  Neurol Clin       Date:  2019-08-27       Impact factor: 3.806

4.  Information about migraine disability influences physicians' perceptions of illness severity and treatment needs.

Authors:  W F Holmes; E A MacGregor; J P Sawyer; R B Lipton
Journal:  Headache       Date:  2001-04       Impact factor: 5.887

Review 5.  Impact of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andrée
Journal:  J Headache Pain       Date:  2008-04-17       Impact factor: 7.277

6.  Predictors of outcome in headache patients presenting to family physicians--a one year prospective study. The Headache Study Group of The University of Western Ontario.

Authors: 
Journal:  Headache       Date:  1986-06       Impact factor: 5.887

7.  Are Methods for Evaluating Medications Appropriate for Evaluating Nonpharmacological Treatments for Pain?-Challenges for an Emerging Field of Research.

Authors:  Daniel C Cherkin
Journal:  JAMA Intern Med       Date:  2021-03-01       Impact factor: 21.873

8.  Interictal burden attributable to episodic headache: findings from the Eurolight project.

Authors:  Christian Lampl; Hallie Thomas; Lars Jacob Stovner; Cristina Tassorelli; Zaza Katsarava; Jose Miguel Laínez; Michel Lantéri-Minet; Daiva Rastenyte; Elena Ruiz de la Torre; Colette Andrée; Timothy J Steiner
Journal:  J Headache Pain       Date:  2016-02-16       Impact factor: 7.277

9.  United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.

Authors:  Sarah N Gibbs; Shweta Shah; Chinmay G Deshpande; Mark E Bensink; Michael S Broder; Paula K Dumas; Dawn C Buse; Pamela Vo; Todd J Schwedt
Journal:  Headache       Date:  2020-05-05       Impact factor: 5.887

10.  Systematic review of outcomes and endpoints in preventive migraine clinical trials.

Authors:  James S McGinley; Carrie R Houts; Tracy K Nishida; Dawn C Buse; Richard B Lipton; Peter J Goadsby; David W Dodick; R J Wirth
Journal:  Headache       Date:  2021-02-18       Impact factor: 5.887

View more
  3 in total

1.  The value of the patient perspective in understanding the full burden of migraine.

Authors:  Rebecca Erwin Wells; Paige M Estave; Rebecca Burch; Niina Haas; Scott W Powers; Elizabeth Seng; Dawn C Buse; Richard B Lipton
Journal:  Headache       Date:  2021-07       Impact factor: 5.311

2.  Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.

Authors:  Robert P Cowan; Michael J Marmura; Hans-Christoph Diener; Amaal J Starling; Jack Schim; Joe Hirman; Thomas Brevig; Roger Cady
Journal:  J Headache Pain       Date:  2022-09-06       Impact factor: 8.588

Review 3.  Migraine in the workplace.

Authors:  Olivia Begasse de Dhaem; Fumihiko Sakai
Journal:  eNeurologicalSci       Date:  2022-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.